Your Messages Inbox
Your Article Summary
See Latest ArticlesAllos Therapeutics Announces Proposed Public Offering of Common Stock
Allos Therapeutics, 10/06/09
Allos Therapeutics, Inc. announced that it is offering to sell, subject to market and other conditions, 11,000,000 primary shares of its common stock pursuant to an effective shelf registration statement in an underwritten public offering. Allos Therapeutics also intends to grant the underwriters a 30–day option to purchase up to an aggregate of 1,650,000 additional primary shares of common stock to cover over–allotments, if any.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Prodesses ProParaflu+(TM) Assay Cleared for US Marketing by FDA
Gen-Probe, 12/03/09
Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
Shire, 12/03/09
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Article Search
Sponsor